Ann: Annual Report to Shareholders, page-6

The annual report is a positive read in my view as the numbers clearly show:

Financial Summary (key metrics)

		2022	2021
1	Profit & Loss Statement:
2	Revenue	$19.4m	$6.7m
3	Reported Profit/(Loss) from continued operations	$(7.7)m	$(3.9)m
4	Non cash addbacks:	$11.9m	$4.0m
5	Adjusted Profit/(Loss) for non cash items	$4.2m	$0.1m
6
7	Cash Flow:
8	Net Cash Flow from Operating Activities	$6.0m	$(5.5)m
9
10	Balance Sheet:
11	Cash on Hand	$13.8m	$0.6m
12	Borrowings	$nil	$0.3m

Note: the non cash addback was primarily the complete write off of $8.1m for Xanada (TP/15) which now written off can never re-occur.

More points to come as I wade through the report.

IMO and DYOR.